Valuation: Danaher Corporation

Market Cap 137B 120B 111B 102B 194B 13,006B 198B 1,325B 515B 6,419B 514B 503B 22,186B P/E 2026 *
30.8x
P/E 2027 * 25.4x
Enterprise Value 137B 120B 111B 102B 194B 13,006B 198B 1,325B 515B 6,419B 514B 503B 22,186B EV / Sales 2026 *
5.26x
EV / Sales 2027 * 4.83x
Free-Float
71.14%
Yield 2026 *
0.75%
Yield 2027 * 0.79%
1 day+0.29%
1 week+1.95%
Current month+1.95%
1 month+5.81%
3 months+1.66%
6 months-17.57%
Current year-15.17%
1 week 189.78
Extreme 189.78
198.23
1 month 174.22
Extreme 174.2162
198.23
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
333.96
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 31/08/2020
Director of Finance/CFO - 27/02/2026
Chief Tech/Sci/R&D Officer - 24/08/2025
Director TitleAgeSince
Director/Board Member 74 30/06/1999
Chairman 74 31/12/1983
Director/Board Member 69 31/12/1983
Date Insider Type Main position Quantity % Market Cap.
05-14Free

Director

2,379 0.0003%
05-14Free

Director

2,379 0.0003%
05-14Free

Director

2,379 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+0.29%+1.95%-2.73%-16.69% 137B
-0.19%+3.04%+23.39%+0.56% 192B
-1.28%+7.45%-20.09%+28.98% 153B
+1.57%+6.14%-56.37%-13.37% 66.29B
-0.38%+4.82%+23.64%+5.05% 54.8B
+1.06%+3.07%-24.36%-28.90% 44.44B
-1.05%-0.03%+8.13%+41.94% 37.2B
+0.41%-1.27%+9.97%+12.09% 36.89B
+0.62%+12.76%-14.30%+1.83% 31.5B
+0.08%+1.37%-13.03%-18.50% 29.5B
Average +0.04%+2.68%-6.57%+1.30% 78.33B
Weighted average by Cap. -0.24%+3.15%-3.37%+2.41%

Financials

2026 *2027 *
Net sales 26.06B 22.8B 21.01B 19.48B 36.97B 2,473B 37.57B 252B 97.99B 1,220B 97.82B 95.7B 4,218B 28.37B 24.83B 22.88B 21.21B 40.26B 2,693B 40.91B 274B 107B 1,329B 107B 104B 4,593B
Net income 4.42B 3.87B 3.56B 3.3B 6.27B 419B 6.37B 42.71B 16.61B 207B 16.58B 16.22B 715B 5.35B 4.68B 4.31B 4B 7.59B 508B 7.71B 51.72B 20.11B 250B 20.08B 19.64B 866B
Net Debt - -
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
07/07/26 US$194.19 +0.29% 3,247,422
06/07/26 US$193.62 -2.18% 4,663,821
02/07/26 US$197.93 +2.17% 4,035,515
01/07/26 US$193.72 +1.70% 4,515,633
30/06/26 US$190.48 -1.19% 3,471,399
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
193.62USD
Average target price
242.26USD
Spread / Average Target
+25.12%

Quarterly revenue - Rate of surprise